144 related articles for article (PubMed ID: 22427552)
1. A novel cyclosporin a aqueous formulation for dry eye treatment: in vitro and in vivo evaluation.
Di Tommaso C; Valamanesh F; Miller F; Furrer P; Rodriguez-Aller M; Behar-Cohen F; Gurny R; Möller M
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2292-9. PubMed ID: 22427552
[TBL] [Abstract][Full Text] [Related]
2. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
[TBL] [Abstract][Full Text] [Related]
3. In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease.
Rodriguez-Aller M; Kaufmann B; Guillarme D; Stella C; Furrer P; Rudaz S; El Zaoui I; Valamanesh F; Di Tommaso C; Behar-Cohen F; Veuthey JL; Gurny R
Eur J Pharm Biopharm; 2012 Apr; 80(3):544-52. PubMed ID: 22155591
[TBL] [Abstract][Full Text] [Related]
4. Distribution of cyclosporine A in ocular tissues after topical administration of cyclosporine A cationic emulsions to pigmented rabbits.
Daull P; Lallemand F; Philips B; Lambert G; Buggage R; Garrigue JS
Cornea; 2013 Mar; 32(3):345-54. PubMed ID: 23023401
[TBL] [Abstract][Full Text] [Related]
5. Treatment of endotoxin-induced uveitis by topical application of cyclosporine a-loaded PolyGel™ in rabbit eyes.
Alshamsan A; Abul Kalam M; Vakili MR; Binkhathlan Z; Raish M; Ali R; Alturki TA; Safaei Nikouei N; Lavasanifar A
Int J Pharm; 2019 Oct; 569():118573. PubMed ID: 31356955
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid coated poly-epsilon-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea.
Yenice I; Mocan MC; Palaska E; Bochot A; Bilensoy E; Vural I; Irkeç M; Hincal AA
Exp Eye Res; 2008 Sep; 87(3):162-7. PubMed ID: 18675411
[TBL] [Abstract][Full Text] [Related]
7. Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: Improving in vivo ocular distribution.
Shen J; Deng Y; Jin X; Ping Q; Su Z; Li L
Int J Pharm; 2010 Dec; 402(1-2):248-53. PubMed ID: 20934499
[TBL] [Abstract][Full Text] [Related]
8. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
Toker E; Asfuroğlu E
Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
[TBL] [Abstract][Full Text] [Related]
9. Ocular Distribution of Cyclosporine Following Topical Administration of OTX-101 in New Zealand White Rabbits.
Weiss SL; Kramer WG
J Ocul Pharmacol Ther; 2019 Sep; 35(7):395-402. PubMed ID: 31355703
[No Abstract] [Full Text] [Related]
10. Cyclosporin A-loaded poly(ethylene glycol)-b-poly(d,l-lactic acid) micelles: preparation, in vitro and in vivo characterization and transport mechanism across the intestinal barrier.
Zhang Y; Li X; Zhou Y; Fan Y; Wang X; Huang Y; Liu Y
Mol Pharm; 2010 Aug; 7(4):1169-82. PubMed ID: 20540526
[TBL] [Abstract][Full Text] [Related]
11. Ocular distribution of cyclosporin A (Sandimmun) following systemic and topical administration to rabbits.
Vernillet L; Lundh RL; Acezat-Mispelter F; Goizel C; Humbert H; Pouliquen Y
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():150-8. PubMed ID: 1820870
[TBL] [Abstract][Full Text] [Related]
12. Self-assembling colloidal system for the ocular administration of cyclosporine A.
Luschmann C; Tessmar J; Schoeberl S; Strauß O; Luschmann K; Goepferich A
Cornea; 2014 Jan; 33(1):77-81. PubMed ID: 24162754
[TBL] [Abstract][Full Text] [Related]
13. Slitlamp biomicroscopy of the tear film of patients using topical Restasis and Refresh Endura.
Solomon R; Perry HD; Donnenfeld ED; Greenman HE
J Cataract Refract Surg; 2005 Apr; 31(4):661-3. PubMed ID: 15899439
[TBL] [Abstract][Full Text] [Related]
14. A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kinetics.
Lallemand F; Furrer P; Felt-Baeyens O; Gex-Fabry M; Dumont JM; Besseghir K; Gurny R
Int J Pharm; 2005 May; 295(1-2):7-14. PubMed ID: 15847987
[TBL] [Abstract][Full Text] [Related]
15. Ocular surface distribution and pharmacokinetics of a novel ophthalmic 1% azithromycin formulation.
Akpek EK; Vittitow J; Verhoeven RS; Brubaker K; Amar T; Powell KD; Boyer JL; Crean C
J Ocul Pharmacol Ther; 2009 Oct; 25(5):433-9. PubMed ID: 19857105
[TBL] [Abstract][Full Text] [Related]
16. Ocular delivery systems for poorly soluble drugs: an in-vivo evaluation.
Luschmann C; Herrmann W; Strauss O; Luschmann K; Goepferich A
Int J Pharm; 2013 Oct; 455(1-2):331-7. PubMed ID: 23867983
[TBL] [Abstract][Full Text] [Related]
17. Eye drop delivery of nano-polymeric micelle formulated genes with cornea-specific promoters.
Tong YC; Chang SF; Liu CY; Kao WW; Huang CH; Liaw J
J Gene Med; 2007 Nov; 9(11):956-66. PubMed ID: 17724775
[TBL] [Abstract][Full Text] [Related]
18. Semifluorinated alkanes as a liquid drug carrier system for topical ocular drug delivery.
Dutescu RM; Panfil C; Merkel OM; Schrage N
Eur J Pharm Biopharm; 2014 Sep; 88(1):123-8. PubMed ID: 24844949
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine Amicellar delivery system for dry eyes.
Kang H; Cha KH; Cho W; Park J; Park HJ; Sun BK; Hyun SM; Hwang SJ
Int J Nanomedicine; 2016; 11():2921-33. PubMed ID: 27382280
[TBL] [Abstract][Full Text] [Related]
20. [The immunosuppressive effects of 0.025% cyclosporin eye drops in alpha cyclodextrin on rabbit corneal allografts].
Takano T; Kobayashi C; Alba RM; Kanai A
Nippon Ganka Gakkai Zasshi; 1992 Jul; 96(7):834-40. PubMed ID: 1502981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
